Riskpilot← Back to searchSign inGet full accessGENETECH NORGE AS
ASActiveOrg 956411785Marenlundveien 6, 2020 SkedsmokorsetWholesale of other machinery and equipment · NACE 4664Est. 19903 employees
Revenue 2024
NOK 17,6M
-32% vs 2023
EBITDA margin
10.7%
-21% vs 2023
Equity ratio
49.5%
Financial strength
Net profit 2024
NOK 1,2M
-28% vs 2023
| Revenue | NOK 17,6M | -32% |
| EBITDA | NOK 1,9M | -21% |
| Net profit | NOK 1,2M | -28% |
| Total assets | NOK 7M | -33% |
| Equity | NOK 3,5M | +7% |
| Employees | 3 | — |
Legal name
GENETECH NORGE AS
Org number
956411785
Legal form
Aksjeselskap
NACE code
4664 · Wholesale of other machinery and equipment
Founded
15. januar 1990
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Marenlundveien 6, 2020 Skedsmokorset
Phone
+4732801030
Email
salg@scanslep.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 13 138 | 9 496 | 12 617 | 11 180 | 16 665 | 16 415 | 14 059 | 12 896 | 13 019 | 13 056 | 10 568 | 9 878 | 9 737 | 17 855 | 18 662 | 25 767 | 17 566 |
| Staff expenses | −0 | −1 814 | −1 855 | −2 011 | −1 670 | −2 443 | −2 704 | −2 189 | −2 278 | −2 458 | −2 336 | −2 369 | −2 362 | −1 760 | −2 439 | −2 949 | −3 176 | −3 086 |
| EBITDA | 0 | 545 | 970 | 1 568 | 1 546 | 1 406 | 1 633 | 919 | 548 | 719 | 84 | 277 | 350 | 169 | 2 022 | 1 937 | 2 383 | 1 884 |
| Depreciation & amort. | −0 | −104 | −206 | −100 | −100 | −60 | −60 | −50 | −0 | −5 | −13 | −8 | −14 | −28 | −24 | −109 | −182 | −192 |
| EBIT | 0 | 441 | 764 | 1 468 | 1 447 | 1 346 | 1 573 | 869 | 548 | 714 | 72 | 270 | 336 | 141 | 1 999 | 1 828 | 2 201 | 1 692 |
| Net financials | 0 | −18 | −1 | −2 | 5 | −22 | −0 | −3 | 5 | 17 | 13 | 18 | −11 | 86 | −24 | 11 | 14 | −68 |
| Profit before tax | 0 | 423 | 764 | 1 466 | 1 452 | 1 324 | 1 573 | 866 | 553 | 730 | 85 | 288 | 326 | 227 | 1 975 | 1 840 | 2 215 | 1 624 |
| Tax | −0 | 139 | 207 | 433 | 429 | 377 | 472 | 248 | 157 | 189 | 22 | 51 | 92 | 74 | 430 | 376 | 494 | 387 |
| Net profit | 0 | 284 | 556 | 1 033 | 1 024 | 947 | 1 101 | 618 | 397 | 542 | 63 | 237 | 234 | 153 | 1 545 | 1 464 | 1 720 | 1 237 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 4 587 | 3 863 | 5 153 | 5 169 | 6 529 | 7 453 | 6 564 | 6 527 | 6 314 | 5 426 | 4 407 | 4 267 | 3 751 | 6 091 | 7 092 | 10 577 | 7 038 |
| Equity | — | 1 016 | 1 173 | 1 406 | 1 629 | 2 577 | 3 178 | 3 396 | 3 792 | 3 834 | 3 396 | 3 133 | 2 867 | 2 520 | 3 065 | 3 528 | 3 249 | 3 486 |
| Long-term debt | 0 | 118 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 219 | 128 | 39 |
| Short-term debt | 0 | 3 452 | 2 681 | 3 747 | 3 540 | 3 952 | 4 275 | 3 168 | 2 735 | 2 480 | 2 030 | 1 274 | 1 400 | 1 231 | 3 027 | 3 345 | 7 200 | 3 514 |
| Total debt | 0 | 3 571 | 2 690 | 3 747 | 3 540 | 3 952 | 4 275 | 3 168 | 2 735 | 2 480 | 2 030 | 1 274 | 1 400 | 1 231 | 3 027 | 3 564 | 7 328 | 3 553 |
EBITDA margin
10.7%
This company
15.8%
Market median
-32% vs market
20072024
Equity ratio
49.5%
This company
38.2%
Market median
+30% vs market
20072024
Return on equity
35.5%
This company
18.4%
Market median
+93% vs market
20072024
Net profit margin
7.0%
This company
8.1%
Market median
-14% vs market
20072024
Asset turnover
2.50×
This company
1.12×
Market median
+123% vs market
20072024
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PS Deputy Member | Deputy Member | 2015 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Cean As | Company | 97.5% | 97.5% | 2024 |
| Individual | 2.5% | 2.5% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Cean As
GENETECH NORGE AS Board members of GENETECH NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Sigval Jacobsen | Deputy Member | 0 companies |